Infection and pathogenesis of a murine strain of Escherichia coli with genetically introduced Shiga toxin type I operon in conventional mice

Microbial Pathogenesis

Volumn 33, Issue 2, 2002, Pages 63-72

  Nakagawa, Ichiro ^a   Nakata, Masanobu ^a   Yamamura, Taihei ^a   Wakisaka, Satoshi ^a   Kawabata, Shigetada ^a   Hamada, Shigeyuki ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Conventional mice; Escherichia coli; Shiga toxin

Indexed keywords

SHIGA TOXIN;

ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; ESCHERICHIA COLI; GENETIC STRAIN; HISTOPATHOLOGY; INFLAMMATION; INOCULATION; INTESTINE; KIDNEY; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; OPERON; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; VIRULENCE;

ESCHERICHIA COLI; MURINAE;

EID: 0036385847     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1006/mpat.2002.0518     Document Type: Article

References (40)

1. Goldwater PN, Bettelheim KA. New perspectives on the role of Escherichia coli O157:H7 and other enterohaemorrhagic E. coli serotypes in human disease. J Med Microbiol 1998; 47: 1039-45.
2. Feng P. Escherichia coli serotype O157:H7: novel vehicles of infection and emergence of phenotypic variants. Emerg Infect Dis 1995; 1: 47-52.
3. Jerse AE, Yu J, Tall BD, Kaper JB. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci USA 1990; 87: 7839-43.
4. O'Brien AD, Holmes RK. Shiga and Shiga-like toxin. Microbiol Rev 1987; 51: 206-20.
5. Cornick NA, Matise I, Samunel JE, Bosworth BT, Moon HW. Shiga toxin-producing Escherichia coli infection: temporal and quantitative relationships among colonization, toxin production, and systemic disease. J Infect Dis 2000; 181: 242-51.
6. Beutin L, Montenegro MA, Orskov I et al. Close association of verotoxin (Shiga-like toxin) production with enterohaemolysin production in strains of Escherichia coli. J Clin Microbiol 1989; 27: 2559-64.
7. Schmidt H, Beutin L, Karch H. Molecular analysis of the plasmid-encoded haemolysin of Escherichia coli O157:H7 strain EDL 933. Infect Immun 1995; 63: 1055-61.
8. Karmali MA, Petric M, Lim C, Fleming PC, Arbus GS, Lior H. The association between idiopathic haemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 1985; 151: 775-82.
9. Karpman D, Connell H, Svensson M, Scheutz F, Alm P, Svanborg C. The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection. J Infect Dis 1997; 175: 611-20.
10. Chae C, Moxley RA, Christopher-Hennings J, Francis DH, Wannemuehler MJ. Shiga-like toxin-II-producing Escherichia coli O157:H7 infection in Gnotobiotic piglets: Protection againist brain vascular lesions with SLT-II antiserum. In: Karmali MA, Goglio AG, Eds. Recent Advances in Verotixin-producing Escherichia coli Infections. Amsterdam: Elsevier, 1994: 241-4.
11. Tzipori S, Karch H, Wachsmuth KI et al. Role of a 60-megadalton plasmid and Shiga-like toxins in the pathogenesis of infection caused by enterohaemorrhagic Escherichia coli O157:H7 in gnotobiotic piglets. Infect Immun 1987; 55: 3117-25.
12. Francis DH, Collins JE, Duimstra JR. Infection of gnotobiotic pigs with an Escherichia coli O157:H7 strain associated with an outbreak of haemorrhagic colitis. Infect Immun 1986; 51: 953-6.
13. Pai CH, Kelly JK, Meyers GL. Experimental infection of infant rabbits with verotoxin-producing Escherichia coli. Infect Immun 1986; 51: 16-23.
14. Wadolkowski EA, Sung LM, Burris JA, Samuel JE, O'Brien AD. Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II. Infect Immun 1990; 58: 3959-65.
15. Wadolkowski EA, Burris JA, O'Brien AD. Mouse model for colonization and disease caused by enterohaemorrhagic Escherichia coli O157:H7. Infect Immun 1990; 58: 2438-45.
16. Isogai E, Isogai H, Kimura K et al. Role of tumour necrosis factor alpha in gnotobiotic mice infected with an Escherichia coli O157:H7 strain. Infect Immun 1998; 66: 197-202.
17. Kurioka T, Yunou Y, Kita E. Enhancement of susceptibility to Shiga toxin-producing Escherichia coli O157:H7 by protein calorie malnutrition in mice. Infect Immun 1998; 66: 1726-34.
18. Richardson SE, Rotman TA, Jay V et al. Experimental verocytotoxemia in rabbits. Infect Immun 1992; 60: 4154-67.
19. Tesh VL, Burris JA, Owens JW et al. Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect Immun 1993; 61: 3392-402.
20. Harel Y, Silva M, Giroir B, Weinberg A, Cleary TB, Beutler B. A reporter transgene indicates renal-specific induction of tumour necrosis factor (TNF) by shiga-like toxin. Possible involvement of TNF in haemolytic uremic syndrome. J Clin Invest 1993; 92: 2110-6.
21. Jacewicz M, Clausen H, Nudelman E, Donohue-Rolfe A, Keusch GT. Pathogenesis of shigella diarrhoea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide. J Exp Med 1986; 163: 1391-404.
22. Tesh VL, O'Brien AD. The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins. Mol Microbiol 1991; 5: 1817-22.
23. Lindgren SW, Melton AR, O'Brien AD. Virulence of enterohaemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model. Infect Immun 1993; 61: 3832-42.
24. Kaplan BS, Cleary TG, Obrig TG. Recent advances in understanding the pathogenesis of the haemolytic uraemic syndromes. Pediatr Nephrol 1990; 4: 76-83.
25. Cimolai N, Morrison BJ, Carter JE. Risk factors for the central nervous system manifestations of gastroenteritis-associated haemolytic-uraemic syndrome. Pediatrics 1992; 90: 616-21.
26. Neild GH. Haemolytic-uraemic syndrome in practice. Lancet 1994; 343: 389-401.
27. Localization of Shiga toxins of enterohaemorrhagic Escherichia coli in kidneys of paediatric and geriatric patients with fatal haemolytic uraemic syndrome. Microb Pathog 2001; 2: 59-67.
28. Hamano S, Nakanishi Y, Nara T, Seki T, Ohtani T, Oishi T et al. Neurologic manifestations of hemorrhagic colitis in the outbreak of Escherichia coli O157:H7 infection in Japan. Acta Paediatr 1993; 82: 454-8.
29. Ong AC, Fine LG. Loss of glomerular function and tuburointerstitial fibrosis: Cause or effect? Kidney Int 1994; 45: 345-51.
30. McKee ML, Melton-Celsa AR, Moxley RA, Francis DH, O'Brien AD. Enterohaemorrhagic Escherichia coli O157:H7 requires intimin to colonize the gnotobiotic pig intestine and to adhere to HEp-2 cells. Infect Immun 1995; 63: 3739-44.
31. Tesh VL, O'Brien AD. Adherence and colonization mechanisms of enteropathogenic and enterohaemorrhagic Escherichia coli. Microb Pathog 1992; 12: 245-54.
32. van Setten PA, Monnens LA, Verstraten RG, van den Heuvel LP, van Hinsbergh VW. Effects of verocyto-toxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release. Blood 1996; 88: 174-83.
33. Lopez EL, Prado-Jimenez V, O'Ryan-Gallardo M, Contrini MM. Shigella and Shiga toxin-producing Escherichia coli bloody diarrhoea in Latin America. Infect Dis Clin North Am 2000; 14: 41-65.
34. van de Kar NC, Sauerwein RW, Demacker PN, Grau GE, van Hinsbergh VW, Monnens LA. Plasma cytokine levels in haemolytic uraemic syndrome. Nephron 1995; 71: 309-13.
35. Siegler RL, Edwin SS, Christofferson RD, Mitchell MD. Plasma and urinary cytokines in childhood haemolytic uraemic syndrome (HUS). J Am Soc Nephrol 1991; 2: Abstract 70P.
36. Tesh VL. Cytokine response to Shiga toxin. In: Kaper JB, O'Brien AD, eds. Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. Washington: ASM Press, 1998; 226-35.
37. Song DK, Im YB, Jung JS et al. Differential involvement of central and peripheral norepinephrine in the central lipopolysaccharide-induced interleukin-6 responses in mice. J Neurochem 1999; 72: 1625-33.
38. Edward U, Rogall T, Bloecher H, Emde M, Boettger EC. Isolation and direct complete nucleotide determination of entire genes. Characterization of a gene coding for 16S ribosomal RNA. Nucleic Acids Res 1989; 28: 1942-46.
39. Reed LJ, Muench H. A simple method of estimating fifty percent end points. Am J Hyg 1938; 27: 293-9.
40. Mizuno S, Yue BF, Okamoto M, Horikawa Y, Kurosawa T. Diffuse glomerulosclerosis without tubular injury does not directly manifest renal dysfunction in nephrotic mice (ICGN strain). Exp Nephrol 1997; 5: 498-507.